Literature DB >> 23872790

Patient-reported hereditary breast and ovarian cancer in a primary care practice.

John M Quillin1, Alexander H Krist, Maria Gyure, Rosalie Corona, Vivian Rodriguez, Joseph Borzelleca, Joann N Bodurtha.   

Abstract

Identifying women appropriate for cancer genetic counseling referral depends on patient-reported family history. Understanding predictors of reporting a high-risk family is critical in ensuring compliance with current referral guidelines. Our objectives were to (1) assess prevalence of candidates for BRCA1 and BRCA2 counseling referral in a primary care setting, (2) explore associations with high-risk status and various patient (e.g., race) and family structure (e.g., number of relatives) characteristics, and (3) determine whether high-risk patients had genetic counseling and/or testing. Survey and pedigree data were collected between 2010 and 2012 for 486 Women's Health Clinic patients. Analyses in 2013 investigated perceived cancer risk and worry, family structure, and receipt of genetic counseling. We explored whether these were associated with meeting USPSTF guidelines for genetic counseling referral. Twenty-two (4.5 %) women met the criteria for BRCA referral. Only one of these women had previous genetic counseling, and one reported prior genetic testing. Older women were more likely to meet BRCA referral criteria (P < 0.001). Although perceived risk was higher among high-risk women, 27 % of high-risk women felt their breast cancer risk was "low", and 32 % felt their risk was lower than average. About one in 22 women in primary care may require genetics services for hereditary breast and ovarian cancer, but alarmingly, few actually receive these services. Also, a significant proportion do not perceive that they are at increased risk. Educational interventions may be needed for both providers and patients to increase awareness of familial risk and appropriate genetic counseling services.

Entities:  

Year:  2013        PMID: 23872790      PMCID: PMC3955454          DOI: 10.1007/s12687-013-0161-1

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  20 in total

Review 1.  Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2005-09-06       Impact factor: 25.391

2.  Clinically relevant changes in family history of cancer over time.

Authors:  Argyrios Ziogas; Nora K Horick; Anita Y Kinney; Jan T Lowery; Susan M Domchek; Claudine Isaacs; Constance A Griffin; Patricia G Moorman; Karen L Edwards; Deirdre A Hill; Jonathan S Berg; Gail E Tomlinson; Hoda Anton-Culver; Louise C Strong; Carol H Kasten; Dianne M Finkelstein; Sharon E Plon
Journal:  JAMA       Date:  2011-07-13       Impact factor: 56.272

3.  ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure.

Authors: 
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.

Authors:  Hayley S Thompson; Katarina Sussner; Marc D Schwartz; Tiffany Edwards; Andrea Forman; Lina Jandorf; Karen Brown; Dana H Bovbjerg; Heiddis B Valdimarsdottir
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-11

Review 5.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history.

Authors:  Harvey J Murff; David R Spigel; Sapna Syngal
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

6.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

7.  The rapid estimate of adult literacy in genetics (REAL-G): a means to assess literacy deficits in the context of genetics.

Authors:  Lori H Erby; Debra Roter; Susan Larson; Juhee Cho
Journal:  Am J Med Genet A       Date:  2008-01-15       Impact factor: 2.802

8.  Cancer genetics evaluation: barriers to and improvements for referral.

Authors:  Rachael Brandt; Zonera Ali; Allison Sabel; Terri McHugh; Paul Gilman
Journal:  Genet Test       Date:  2008-03

9.  Validation of family history data in cancer family registries.

Authors:  Argyrios Ziogas; Hoda Anton-Culver
Journal:  Am J Prev Med       Date:  2003-02       Impact factor: 5.043

10.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

View more
  9 in total

1.  Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.

Authors:  Alyssa Kne; Heather Zierhut; Shari Baldinger; Karen K Swenson; Pamela Mink; Patricia McCarthy Veach; Michaela L Tsai
Journal:  J Genet Couns       Date:  2016-11-08       Impact factor: 2.537

2.  Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer.

Authors:  Robert A Bell; Haley McDermott; Tonya L Fancher; Michael J Green; Frank C Day; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2014-12-02       Impact factor: 5.128

3.  A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.

Authors:  Kent F Hoskins; Silvia Tejeda; Ganga Vijayasiri; Ifeanyi Beverly Chukwudozie; Mylene H Remo; Hiral A Shah; Ivy E Abraham; Lara E Balay; Tara K Maga; Ericka R Searles; Veena J Korah; Alana Biggers; Melinda R Stolley; Richard B Warnecke
Journal:  Cancer       Date:  2018-10-15       Impact factor: 6.860

4.  Primary care physician referral practices regarding BRCA1/2 genetic counseling in a major health system.

Authors:  Debra T Linfield; Michael B Rothberg; Elizabeth R Pfoh; Ryan Noss; Lydia Cassard; Joseph C Powers; Laura Lipold; Kathryn A Martinez
Journal:  Breast Cancer Res Treat       Date:  2022-07-16       Impact factor: 4.624

5.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

6.  Public awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.

Authors:  Alicia A Parkman; Joan Foland; Beth Anderson; Debra Duquette; Holly Sobotka; Mary Lynn; Shelley Nottingham; William David Dotson; Katherine Kolor; Summer L Cox
Journal:  J Genet Couns       Date:  2014-09-23       Impact factor: 2.537

Review 7.  Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.

Authors:  Katherine Karakasis; Julia V Burnier; Valerie Bowering; Amit M Oza; Stephanie Lheureux
Journal:  Front Oncol       Date:  2016-05-11       Impact factor: 6.244

8.  Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.

Authors:  Christina Evers; Christine Fischer; Nicola Dikow; Sarah Schott
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

9.  Identifying patients with a history of ovarian cancer for referral for genetic counselling: non-randomised comparison of two case-finding strategies in primary care.

Authors:  Charles W Helsper; Liesbeth M Van Vliet; Mary E Velthuizen; Niek J de Wit; Roy Ph Beijaert; Els Butter; Marleen Pl van Gent-Wagemakers; Els O Witteveen; Ronald P Zweemer; Sandra M van Dulmen; Margreet Gem Ausems
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.